AFX-221

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAFX-221
Drug Alias NameMolindone - Afecta PharmaceuticalsAFX-221NGI-221
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurotransmitter receptor modulatorsDopamine D2 receptor antagonists
TargetsNeurotransmitter receptorDopamine D2 receptor
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityTourette Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAfecta Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAfecta Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with HyperactivityTourette Syndrome

Other Information

ATC CodeN/A
Related LinksN/A